Interferon-α 2b plus ribavirin in patients with chronic hepatitis C after liver transplantation: A randomized study
- 1 March 2003
- journal article
- clinical trial
- Published by Elsevier BV in Gastroenterology
- Vol. 124 (3), 642-650
- https://doi.org/10.1053/gast.2003.50095
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- Ribavirin and interferon combination for recurrent post-transplant hepatitis C: which benefit beyond 6 months?Journal of Hepatology, 2002
- Combined therapy with interferon and low-dose ribavirin in posttransplantation recurrent hepatitis C: A pragmatic studyLiver Transplantation, 2001
- Recurrent hepatitis C after liver transplantation: A nonrandomized trial of interferon alfa alone versus interferon alfa and ribavirinLiver Transplantation, 2001
- Hepatitis C–induced hepatic allograft injury is associated with a pretransplantation elevated viral replication rateHepatology, 2000
- High incidence of allograft cirrhosis in hepatitis C virus genotype 1b infection following transplantation: Relationship with rejection episodesHepatology, 1999
- Long-term longitudinal study of intrahepatic hepatitis C virus replication after liver transplantationHepatology, 1997
- A PILOT STUDY OF RIBAVIRIN THERAPY FOR RECURRENT HEPATITIS C VIRUS INFECTION AFTER LIVER TRANSPLANTATION1Transplantation, 1996
- Ribavirin therapy for hepatitis C infection following liver transplantationTransplant International, 1995
- The course of hepatitis C virus infection after liver transplantationHepatology, 1994
- Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitisHepatology, 1981